A phase I trial of BI 754091, a programmed death receptor 1 (PD-1) inhibitor, in patients with advanced solid tumorsMelissa Johnson,Manish Patel,Lillian Siu,Raid Aljumaily,Mark Kozloff,Ulka Vaishampayan,Mabrouk Elgadi,Miaomiao Ge,Christine Duffy,Ralph Graeser,Susanne Buschke, Sheetal Khedkar,Suzanne F. Jones,Howard A. BurrisAnnals of Oncology(2018)引用 0|浏览31暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要